QR-213

N/A

Report date: 2025/01/26 16:17:08
NME

Base Information

Drug NameQR-213
Drug Alias NameDown regulation inhibitor (Qrono)radiotherapy adjunct (Qrono)QR-213
ClassificationSmall molecules
Mechanisms of ActionT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQrono Inc
China Registration ClassN/A

Develop Information

Active CompaniesQrono Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsHead and Neck NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A